ReviewBioengineering (Basel, Switzerland)2025
The Role of Neck Imaging Reporting and Data System (NI-RADS) in the Management of Head and Neck Cancers.
Review in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Inter-rater reliability of MRI Neck Imaging Reporting and Data System (NI-RADS) in the follow-up of oropharyngeal squamous cell carcinoma.La Radiologia medica · 2026Observational
- Diagnostic performance of the NI-RADS system for detecting recurrence in head and neck squamous cell carcinoma: a monocentric pilot study.Journal of cancer research and clinical oncology · 2026Article
- Use of gadolinium-based contrast agents in head and neck cancer diagnosis, staging, and monitoring: current applications and future perspectives.European radiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review evaluates the current evidence on the use of the Neck Imaging Reporting and Data System (NI-RADS) for the surveillance and early detection of recurrent head and neck cancers. NI-RADS offers a standardized, structured framework specifically tailored for post-treatment imaging, aiding radiologists in differentiating between residual tumors, scar tissue, and post-surgical changes. NI-RADS demonstrated a strong diagnostic performance across multiple studies, with high sensitivity and specificity reported in detecting recurrent tumors at primary and neck sites. Despite these strengths, limitations persist, including a high frequency of indeterminate results and variability in di-agnostic concordance across imaging modalities (computed tomography, magnetic resonance imaging (MRI), positron emission tomography(PET)). The review also highlights the NI-RADS's reproducibility, showing high inter- and intra-reader agreements across different imaging techniques, although some modality-specific differences were observed. While it demonstrates strong diagnostic performance and good reproducibility across imaging modalities, attention is required to address indeterminate imaging findings and the limitations of modality-specific variations. Future studies should focus on integrating advanced imaging characteristics, such as diffusion-weighted imaging and PET/MRI fusion techniques, to further enhance NI-RADS's diagnostic accuracy. Continuous efforts to refine NI-RADS protocols and imaging interpretations will ensure more consistent detection of recurrences, ultimately improving clinical outcomes in head and neck cancer management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.